HK1125371A1 - Substituted arylsulfonamides as antiviral agents - Google Patents

Substituted arylsulfonamides as antiviral agents

Info

Publication number
HK1125371A1
HK1125371A1 HK09104156.3A HK09104156A HK1125371A1 HK 1125371 A1 HK1125371 A1 HK 1125371A1 HK 09104156 A HK09104156 A HK 09104156A HK 1125371 A1 HK1125371 A1 HK 1125371A1
Authority
HK
Hong Kong
Prior art keywords
antiviral agents
substituted arylsulfonamides
arylsulfonamides
substituted
antiviral
Prior art date
Application number
HK09104156.3A
Other languages
English (en)
Inventor
Niels Svenstrup
Holger Zimmermann
Dagmar Karthaus
Andreas Goeller
Dirk Heimbach
Kerstin Henninger
Dieter Lang
Daniela Paulsen
Bernd Riedl
Rudolf Schohe-Loop
Joachim Schuhmacher
Tobias Wunberg
Original Assignee
Aicuris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38180640&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1125371(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aicuris Gmbh filed Critical Aicuris Gmbh
Publication of HK1125371A1 publication Critical patent/HK1125371A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK09104156.3A 2006-03-03 2009-05-05 Substituted arylsulfonamides as antiviral agents HK1125371A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006009928A DE102006009928A1 (de) 2006-03-03 2006-03-03 Substituierte Arylsulfonamide
PCT/EP2007/001620 WO2007101573A1 (de) 2006-03-03 2007-02-26 Substituierte arylsulfonamide als antivirale mittel

Publications (1)

Publication Number Publication Date
HK1125371A1 true HK1125371A1 (en) 2009-08-07

Family

ID=38180640

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09104156.3A HK1125371A1 (en) 2006-03-03 2009-05-05 Substituted arylsulfonamides as antiviral agents

Country Status (26)

Country Link
US (1) US8318761B2 (uk)
EP (1) EP1991529B1 (uk)
JP (1) JP5255455B2 (uk)
KR (1) KR101447758B1 (uk)
CN (1) CN101389607B (uk)
AR (1) AR059710A1 (uk)
AT (1) ATE451356T1 (uk)
AU (1) AU2007222689B2 (uk)
BR (1) BRPI0707068A2 (uk)
CA (1) CA2642602C (uk)
DE (2) DE102006009928A1 (uk)
DK (1) DK1991529T3 (uk)
ES (1) ES2335316T3 (uk)
HK (1) HK1125371A1 (uk)
IL (1) IL193449A (uk)
JO (1) JO2581B1 (uk)
MX (1) MX2008011264A (uk)
PE (1) PE20080136A1 (uk)
PL (1) PL1991529T3 (uk)
PT (1) PT1991529E (uk)
RU (1) RU2423352C2 (uk)
TW (1) TWI388559B (uk)
UA (1) UA95103C2 (uk)
UY (1) UY30178A1 (uk)
WO (1) WO2007101573A1 (uk)
ZA (1) ZA200807189B (uk)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10319612A1 (de) 2003-05-02 2004-11-18 Bayer Healthcare Ag Substituierte Dihydrochinazoline
EP2103317A1 (de) * 2008-03-20 2009-09-23 Bayer MaterialScience AG Medizinische Geräte mit hydrophilen Beschichtungen
EP2103638A1 (de) * 2008-03-20 2009-09-23 Bayer MaterialScience AG Hydrophile Polyurethanlösungen
EP2103318A1 (de) * 2008-03-20 2009-09-23 Bayer MaterialScience AG Medizinische Geräte mit hydrophilen Beschichtungen
EP2103316A1 (de) * 2008-03-20 2009-09-23 Bayer MaterialScience AG Hydrophile Polyurethandispersionen
DE102008025613A1 (de) * 2008-05-28 2009-12-03 Bayer Materialscience Ag Hydrophile Polyurethanbeschichtungen
DE102008025614A1 (de) * 2008-05-28 2009-12-03 Bayer Materialscience Ag Hydrophile Polyurethanbeschichtungen
DK2331156T3 (da) 2008-09-04 2012-05-29 Bayer Materialscience Ag TCD-baserede hydrofile polyurethanopløsninger
DE102011101446A1 (de) * 2011-05-10 2012-11-15 Aicuris Gmbh & Co. Kg Herstellung von "Dense Bodies" (DB)
EP2853532B1 (en) * 2013-09-28 2020-12-09 Instytut Farmakologii Polskiej Akademii Nauk 1,2,4-oxadiazole derivatives as allosteric modulators of metabotropic glutamate receptors belonging to group III
CN109879817B (zh) * 2019-03-19 2020-10-02 扬州大学 甲基二磺隆的制备方法
RU2738848C1 (ru) * 2019-10-24 2020-12-17 Общество с ограниченной ответственностью "Научно-исследовательский институт ХимРар" (ООО "НИИ ХимРар") Ингибитор вируса гепатита В (ВГВ), представляющий собой производные N-{ 3-[6-(диалкиламино)пиридазин-3-ил]фенил} арилсульфонамида и производные N-{ 4-[6-(диалкиламино)пиридазин-3-ил]фенил} арилсульфонамида

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19802437A1 (de) 1998-01-23 1999-07-29 Bayer Ag Verwendung von substituierten Sulfonamiden als anitvirale Mittel und neue Stoffe
US6495578B1 (en) 1999-04-19 2002-12-17 Shionogi & Co., Ltd. Sulfonamide derivatives having oxadiazole rings
DE19920790A1 (de) * 1999-05-06 2000-11-09 Bayer Ag Bis-Sulfonamide mit anti-HCMV-Wirkung
DE19930075A1 (de) 1999-06-30 2001-01-04 Bayer Ag Neue Amino- und Amidosulfonamide als antivirale Mittel
CN1516695A (zh) 2001-04-19 2004-07-28 用作抗病毒剂的芳基磺酰胺类化合物
DE10138578A1 (de) 2001-08-06 2003-02-27 Bayer Ag Heterocyclylarylsulfonamide

Also Published As

Publication number Publication date
MX2008011264A (es) 2008-09-12
PE20080136A1 (es) 2008-04-18
PT1991529E (pt) 2010-01-06
DK1991529T3 (da) 2010-04-12
KR101447758B1 (ko) 2014-10-06
ZA200807189B (en) 2009-12-30
TWI388559B (zh) 2013-03-11
DE502007002264D1 (de) 2010-01-21
UY30178A1 (es) 2007-09-28
DE102006009928A1 (de) 2007-09-06
WO2007101573A1 (de) 2007-09-13
CA2642602A1 (en) 2007-09-13
EP1991529A1 (de) 2008-11-19
PL1991529T3 (pl) 2010-05-31
JO2581B1 (en) 2011-02-27
AU2007222689B2 (en) 2011-11-17
CN101389607A (zh) 2009-03-18
TW200813034A (en) 2008-03-16
CA2642602C (en) 2014-05-13
ATE451356T1 (de) 2009-12-15
JP5255455B2 (ja) 2013-08-07
JP2009529016A (ja) 2009-08-13
RU2008139195A (ru) 2010-04-10
IL193449A (en) 2013-02-28
ES2335316T3 (es) 2010-03-24
US8318761B2 (en) 2012-11-27
BRPI0707068A2 (pt) 2011-04-19
US20090176842A1 (en) 2009-07-09
CN101389607B (zh) 2011-09-07
UA95103C2 (uk) 2011-07-11
KR20080107456A (ko) 2008-12-10
AR059710A1 (es) 2008-04-23
IL193449A0 (en) 2009-05-04
EP1991529B1 (de) 2009-12-09
RU2423352C2 (ru) 2011-07-10
AU2007222689A1 (en) 2007-09-13

Similar Documents

Publication Publication Date Title
HK1125371A1 (en) Substituted arylsulfonamides as antiviral agents
GB0709791D0 (en) Antiviral agents
GB0815968D0 (en) Antiviral agents
IL193107A0 (en) Hetero-bycyclic antiviral compounds
IL195248A0 (en) Atomiser
ZA200710133B (en) Substituted arylpyrazoles as parasiticidal agents
IL187974A0 (en) Atomiser
GB0707000D0 (en) Antiviral agents
IL197814A0 (en) Substituted sulfonamide derivatives
GB0618613D0 (en) Benzopyranone derivatives as antiviral agents
IL192799A0 (en) Substituted 4-phenylpiperidines
PL1854805T3 (pl) Pochodzące z kawy surfaktanty
GB0613952D0 (en) Antiviral agent
GB0805264D0 (en) Antiviral agents
GB0803707D0 (en) Antiviral agent
GB0614034D0 (en) Antiviral compounds
GB0813307D0 (en) Retro-reflector
EP1968975A4 (en) TYLOPHORINANALOGA AS ANTITUMOR
ZA200903382B (en) Substituted 4-imidazoles
EP2127675A4 (en) ANTIVIRAL MEDIUM
ZA200800515B (en) New Salt I
GB0600501D0 (en) Soap
ZA200805520B (en) Triazoloanilinopyrimidine derivatives for use as antiviral agents
GB0814762D0 (en) Antiviral agents
GB0621782D0 (en) Antiviral agent